# Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring <i>MET</i> Mutations Causing Exon 14 Skipping

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/response-to-met-inhibitors-in-patients-with-stage-iv-lung-adenocarcinomas/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Paul K. Paik,Alexander Drilon,Pang‐Dian Fan,Helena A. Yu,Natasha Rekhtman,Michelle S. Ginsberg,Laetitia Borsu,Nikolaus Schultz,Michael F. Berger,Charles M. Rudin,Marc Ladanyi |
| Citations | 573 |
| DOI | 10.1158/2159-8290.cd-14-1467 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/4658654 |
| OpenAlex ID | https://openalex.org/W2169624569 |
| PMID | 25971939 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Natasha Rekhtman](https://scholariq.org/researchers/natasha-rekhtman/)
- [Michael F. Berger](https://scholariq.org/researchers/michael-f-berger/)
- [Helena A. Yu](https://scholariq.org/researchers/helena-a-yu/)
- [Charles M. Rudin](https://scholariq.org/researchers/charles-m-rudin/)
- [Marc Ladanyi](https://scholariq.org/researchers/marc-ladanyi/)

## Paper journal

- [Cancer Discovery](https://scholariq.org/journals/cancer-discovery/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Liver physiology and pathology](https://scholariq.org/topics/liver-physiology-and-pathology/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.